ClinicalTrials.gg
Sign In

Rectal Diseases clinical trials

The registry lists 87 studies for Rectal Diseases across more than 10 countries. 14 are recruiting or about to start. 17 of them are mainly about Rectal Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 17 narrower conditions too, such as Colorectal Neoplasms: 10,927 studies, 2,865 open.

Get an email when these change. Save the Rectal Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
47
Status unknown
11
Terminated
9
Recruiting
8
Not yet recruiting
6
Active, not recruiting
4

Phase

Phase 2
12
Phase 3
9
Phase 1
8
Phase 4
4
Early Phase 1
1

Where

United States
33
China
14
Canada
12
France
8
United Kingdom
7
Poland
5

Who runs them

Exact Sciences Corporation (5) · Royal Marsden NHS Foundation Trust (4) · Medical University of Warsaw (3) · Pfizer (3) · Bausch Health Americas, Inc. (3) · Swedish Medical Center (2) · University Hospitals Cleveland Medical Center (2) · First Affiliated Hospital of Harbin Medical University (2)

What is being tested here

Drugs under test in Rectal Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Anti-PD-1/Anti-VEGF Bispecific Antibody PF-08634404111
Iltamiocel012
Budesonide022
Encorafenib011
Cetuximab011
Oxaliplatin011
Irinotecan011
Leucovorin011
Fluorouracil011
Nitroglycerin001

Coming up

3phase 3 studies under way
6studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6, phase 3 first

Who these studies take

Of the 8 Rectal Diseases studies recruiting now, 6 (75%) set no upper age limit and 1 (13%) stop at 75 or younger. 2 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
102 (25%)2 (25%)
188 (100%)8 (100%)
307 (88%)7 (88%)
407 (88%)7 (88%)
507 (88%)7 (88%)
657 (88%)7 (88%)
757 (88%)7 (88%)
856 (75%)6 (75%)

Across all 87 studies, recruiting or not: 21% stop at 75 or younger and 13% at 65; 8% take children; 2% are for women only and 0% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Rectal Diseases studies take

Of 16 interventional studies with no phase under Rectal Diseases, half reached primary completion within 35 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase35 mo11–57 · 16 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 87. Browse all 87 → or search them.